Mauviel A, Chung K Y, Agarwal A, Tamai K, Uitto J
Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
J Biol Chem. 1996 May 3;271(18):10917-23. doi: 10.1074/jbc.271.18.10917.
Transforming growth factor-beta (TGF-beta) plays a major role in regulating connective tissue deposition by controlling both extracellular matrix production and degradation. In this study, we show that TGF-beta transcriptionally represses both basal and tumor necrosis factor-alpha-induced collagenase (matrix metalloprotease-1) gene expression in dermal fibroblasts in culture, whereas it activates its expression in epidermal keratinocytes. We demonstrate that this differential effect of TGF-beta on collagenase gene expression is due to a cell type-specific induction of distinct oncogenes of the Jun family, which participate in the formation of AP-1 complexes with different trans-activating properties. Specifically, our data indicate that the inhibitory effect of TGF-beta in fibroblasts is likely to be mediated by jun-B, based on the following observations: (a) TGF-beta induces high levels of jun-B expression and (b) over-expression of jun-B mimics TGF-beta effect in inhibiting basal collagenase promoter activity and preventing tumor necrosis factor-alpha-induced trans-activation of the collagenase promoter. In contrast, TGF-beta induction of collagenase gene expression in keratinocytes is preceded by transient elevation of c-jun proto-oncogene expression. Over-expression of c-jun leads to trans-activation of the collagenase promoter in both cell types, suggesting that c-jun is a ubiquitous inducer of collagenase gene expression. Transfection of keratinocytes with an antisense c-jun construct together with a collagenase promoter/reporter gene construct inhibits basal and TGF-beta-induced up-regulation of the collagenase promoter activity, implying that c-jun mediates TGF-beta effect in this cell type. Collectively, our data suggest differential signaling pathways for TGF-beta in dermal fibroblasts and epidermal keratinocytes, leading to cell type-specific induction of two AP-1 components with opposite transcriptional activities.
转化生长因子-β(TGF-β)通过控制细胞外基质的产生和降解,在调节结缔组织沉积中起主要作用。在本研究中,我们发现TGF-β在转录水平上抑制培养的真皮成纤维细胞中基础的和肿瘤坏死因子-α诱导的胶原酶(基质金属蛋白酶-1)基因表达,而在表皮角质形成细胞中它激活该基因的表达。我们证明,TGF-β对胶原酶基因表达的这种差异作用是由于Jun家族不同原癌基因的细胞类型特异性诱导,这些原癌基因参与形成具有不同反式激活特性的AP-1复合物。具体而言,我们的数据表明,基于以下观察结果,TGF-β在成纤维细胞中的抑制作用可能由jun-B介导:(a)TGF-β诱导高水平的jun-B表达;(b)jun-B的过表达模拟了TGF-β在抑制基础胶原酶启动子活性和阻止肿瘤坏死因子-α诱导的胶原酶启动子反式激活方面的作用。相反,TGF-β诱导角质形成细胞中胶原酶基因表达之前,c-jun原癌基因表达会短暂升高。c-jun的过表达导致两种细胞类型中胶原酶启动子的反式激活,这表明c-jun是胶原酶基因表达的普遍诱导剂。用反义c-jun构建体与胶原酶启动子/报告基因构建体共转染角质形成细胞,可抑制基础的和TGF-β诱导的胶原酶启动子活性上调,这意味着c-jun介导了TGF-β在这种细胞类型中的作用。总体而言,我们的数据表明TGF-β在真皮成纤维细胞和表皮角质形成细胞中有不同的信号通路,导致具有相反转录活性的两种AP-1组分的细胞类型特异性诱导。